Inducible Expression of GDNF in Transplanted iPSC-Derived Neural Progenitor Cells

被引:26
作者
Akhtar, Aslam Abbasi [1 ,2 ]
Gowing, Genevieve [1 ]
Kobritz, Naomi [1 ]
Savinoff, Steve E. [1 ]
Garcia, Leslie [1 ]
Saxon, David [1 ]
Cho, Noell [1 ]
Kim, Gibum [1 ]
Tom, Colton M. [1 ]
Park, Hannah [1 ,2 ]
Lawless, George [1 ]
Shelley, Brandon C. [1 ]
Mattis, Virginia B. [1 ,2 ]
Breunig, Joshua J. [1 ,2 ,3 ,4 ]
Svendsen, Clive N. [1 ,2 ]
机构
[1] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA
[2] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA
[3] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA
[4] Cedars Sinai Med Ctr, Ctr Neural Sci & Med, Los Angeles, CA 90048 USA
来源
STEM CELL REPORTS | 2018年 / 10卷 / 06期
关键词
PLURIPOTENT STEM-CELLS; VIVO GENE-THERAPY; NEUROTROPHIC FACTOR; RAT MODEL; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; LENTIVIRAL VECTOR; DOPAMINE NEURONS; MOTOR FUNCTION; DELIVERY;
D O I
10.1016/j.stemcr.2018.03.024
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Trophic factor delivery to the brain using stem cell-derived neural progenitors is a powerful way to bypass the blood-brain barrier. Protection of diseased neurons using this technology is a promising therapy for neurodegenerative diseases. Glial cell line-derived neurotrophic factor (GDNF) has provided benefits to Parkinsonian patients and is being used in a clinical trial for amyotrophic lateral sclerosis. However, chronic trophic factor delivery prohibits dose adjustment or cessation if side effects develop. To address this, we engineered a doxycycline-regulated vector, allowing inducible and reversible expression of a therapeutic molecule. Human induced pluripotent stem cell (iPSC)-derived neural progenitors were stably transfected with the vector and transplanted into the adult mouse brain. Doxycycline can penetrate the graft, with addition and withdrawal providing inducible and reversible GDNF expression in vivo, over multiple cycles. Our findings provide proof of concept for combining gene and stem cell therapy for effective modulation of ectopic protein expression in transplanted cells.
引用
收藏
页码:1696 / 1704
页数:9
相关论文
共 25 条
[1]   A Transposon-Mediated System for Flexible Control of Transgene Expression in Stem and Progenitor-Derived Lineages [J].
Akhtar, Aslam Abbasi ;
Molina, Jessica ;
Dutra-Clarke, Marina ;
Kim, Gi Bum ;
Levy, Rachelle ;
Schreiber-Stainthorp, William ;
Danielpour, Moise ;
Breunig, Joshua J. .
STEM CELL REPORTS, 2015, 4 (03) :323-331
[2]   Human neural progenitors deliver glial cell line-derived neurotrophic factor to parkinsonian rodents and aged primates [J].
Behrstock, S ;
Ebert, A ;
McHugh, J ;
Vosberg, S ;
Moore, J ;
Schneider, B ;
Capowski, E ;
Hei, D ;
Kordower, J ;
Aebischer, P ;
Svendsen, CN .
GENE THERAPY, 2006, 13 (05) :379-388
[3]  
Blesch A, 1996, CLIN NEUROSCI, V3, P268
[4]   Ets Factors Regulate Neural Stem Cell Depletion and Gliogenesis in Ras Pathway Glioma [J].
Breunig, Joshua J. ;
Levy, Rachelle ;
Antonuk, C. Danielle ;
Molina, Jessica ;
Dutra-Clarke, Marina ;
Park, Hannah ;
Akhtar, Aslam Abbasi ;
Kim, Gi Bum ;
Hu, Xin ;
Bannykh, Serguei I. ;
Verhaak, Roel G. W. ;
Danielpour, Moise .
CELL REPORTS, 2015, 12 (02) :258-271
[5]   Lentiviral vector-mediated genetic modification of human neural progenitor cells for ex vivo gene therapy [J].
Capowski, Elizabeth E. ;
Schneider, Bernard L. ;
Ebert, Allison D. ;
Seehus, Corey R. ;
Szulc, Jolanta ;
Zufferey, Romain ;
Aebischer, Patrick ;
Svendsen, Clive N. .
JOURNAL OF NEUROSCIENCE METHODS, 2007, 163 (02) :338-349
[6]   A regulatable AAV vector mediating GDNF biological effects at clinically-approved sub-antimicrobial doxycycline doses [J].
Chtarto, Abdelwahed ;
Humbert-Claude, Marie ;
Bockstael, Olivier ;
Das, Atze T. ;
Boutry, Sebastien ;
Breger, Ludivine S. ;
Klaver, Bep ;
Melas, Catherine ;
Barroso-Chinea, Pedro ;
Gonzalez-Hernandez, Tomas ;
Muller, Robert N. ;
DeWitte, Olivier ;
Levivier, Marc ;
Lundberg, Cecilia ;
Berkhout, Ben ;
Tenenbaum, Liliane .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 :16027
[7]   Clinical trial perspective for adult and juvenile Huntington's disease using genetically-engineered mesenchymal stem cells [J].
Deng, Peter ;
Torrest, Audrey ;
Pollock, Kari ;
Dahlenburg, Heather ;
Annett, Geralyn ;
Nolta, Jan A. ;
Fink, Kyle D. .
NEURAL REGENERATION RESEARCH, 2016, 11 (05) :702-705
[8]   Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease [J].
Ebert, Allison D. ;
Beres, Amy J. ;
Barber, Amelia E. ;
Svendsen, Clive N. .
EXPERIMENTAL NEUROLOGY, 2008, 209 (01) :213-223
[9]   EZ spheres: A stable and expandable culture system for the generation of pre-rosette multipotent stem cells from human ESCs and iPSCs [J].
Ebert, Allison D. ;
Shelley, Brandon C. ;
Hurley, Amanda M. ;
Onorati, Marco ;
Castiglioni, Valentina ;
Patitucci, Teresa N. ;
Svendsen, Soshana P. ;
Mattis, Virginia B. ;
McGivern, Jered V. ;
Schwab, Andrew J. ;
Sareen, Dhruv ;
Kim, Ho Won ;
Cattaneo, Elena ;
Svendsen, Clive N. .
STEM CELL RESEARCH, 2013, 10 (03) :417-427
[10]   Ex vivo delivery of GDNF maintains motor function and prevents neuronal loss in a transgenic mouse model of Huntington's disease [J].
Ebert, Allison D. ;
Barber, Amelia E. ;
Heins, Brittany M. ;
Svendsen, Clive N. .
EXPERIMENTAL NEUROLOGY, 2010, 224 (01) :155-162